Journal of Neuro-Oncology

, Volume 81, Issue 2, pp 217–223

Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91

  • Bernward G. Hinkes
  • Katja von Hoff
  • Frank Deinlein
  • Monika Warmuth-Metz
  • Niels Soerensen
  • Beate Timmermann
  • Uwe Mittler
  • Christian Urban
  • Udo Bode
  • Torsten Pietsch
  • Paul G. Schlegel
  • Rolf D. Kortmann
  • Joachim Kuehl
  • Stefan Rutkowski
Clinical Study - patient studies



To analyze the outcome of children with pineoblastoma (PB), treated within the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91 of German-speaking countries.


We report on 11 children suffering from PB. Five children younger than 3 years of age received chemotherapy after surgery until eligible for radiotherapy (HIT-SKK87 and HIT-SKK92). Five of six children older than 3 years were treated after surgery with immediate chemotherapy and craniospinal irradiation, and one child received maintenance chemotherapy after postoperative radiotherapy (HIT91).


Five of the six older children are still alive in continuous complete remission (CCR) with a median overall survival (OS) and progression free survival (PFS) of 7.9 years. Five of these six HIT91 patients responded to postoperative chemotherapy and radiotherapy. The only patient with tumor progression during initial chemotherapy achieved complete remission with radiotherapy and is alive. In contrast, all five young children died of tumor progression after a median OS of 0.9 years (PFS 0.6 years). They had either metastatic disease (M1) and/or postoperative residual tumor. Response to postoperative chemotherapy was lower than in the older age group, and only one of these children received radiotherapy.


Combined chemotherapy and radiotherapy were feasible and effective in the older age group, leading to prolonged remissions in five of six children. Tumor biology may be more aggressive in younger children with PB, who presented more frequently with high-risk features at diagnosis and had poorer response rates to neoadjuvant postoperative chemotherapy. More intensified treatment regimens may be needed for young children with PB.


Pineoblastoma PNET Supratentorial PNET Young children Chemotherapy Radiotherapy Trial 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kleihues P, Cavenee WK (eds) (2000) World Health Organisation classification of tumors: Pathology and genetics of tumors of the nervous system. IARC Press, Lyon, pp 141–144Google Scholar
  2. 2.
    Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61(3):215–225; discussion 226–229Google Scholar
  3. 3.
    Li MH, Bouffet E, Hawkins CE, Squire JA, Huang A (2005) Molecular genetics of supratentorial primitive neuroectodermal tumors and pineoblastoma. Neurosurg Focus 19(5):E3PubMedGoogle Scholar
  4. 4.
    Raffel C, Jenkins RB, Frederick L et al (1997) Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57:842–845Google Scholar
  5. 5.
    Wechsler-Reya RJ, Scott MP (1999) Control of neuronal precursor proliferation in the cerebellum by sonic hedgehog. Neuron 22:103–114PubMedCrossRefGoogle Scholar
  6. 6.
    Bunett ME, White EC, Sih S, von Haken MS, Cogen PH (1997) Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet 97(1):25–31CrossRefGoogle Scholar
  7. 7.
    Huang H, Mahler-Araujo BM, Sankila A et al (2000) APC mutations in sporadic medulloblastomas. Am J Pathol 156:433–437PubMedGoogle Scholar
  8. 8.
    Fruhwald MC, O’Dorisio MS, Dai Z et al (2001) Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes Chromosomes Cancer 30:38–47PubMedCrossRefGoogle Scholar
  9. 9.
    Reddy AT, Janss AJ, Phillips PC, Weiss HL, Packer RJ (2000) Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer 88:2189–2193PubMedCrossRefGoogle Scholar
  10. 10.
    Jakacki RI (1999) Pineal and nonpineal supratentorial primitive neuroectodermal tumors. Childs Nerv Syst 15:586–591PubMedCrossRefGoogle Scholar
  11. 11.
    Jakacki RI, Zeltzer PM, Boyett JM, Albright AL, Allen JC, Geyer JR, Rorke LB, Stanley P, Stevens KR, Wisoff J et al (1995) Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. J Clin Oncol Jun;13(6):1377–1383Google Scholar
  12. 12.
    Kuehl J, Mueller HL, Berthold F, Kortmann RD, Deinlein F, Maass F, Graf N, Gnekow A, Scheurlen W, Goebel U, Wolf JEA, Bamberg M, Kaatsch P, Kleihues P, Rating D, Soerensen N, Wiestler OD (1998) Pre-irradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT88/89. Klin Paediatr 210:227–233CrossRefGoogle Scholar
  13. 13.
    Cohen BH, Packer RJ (1996) Chemotherapy for medulloblastomas and primitive neuroectodermal tumors. J Neurooncol 29:55–68PubMedCrossRefGoogle Scholar
  14. 14.
    Cohen BH, Zeltzer PM, Boyett JM, Geyer JR, Allen JC, Finlay JL, McGuire-Cullen P, Milstein JM, Rorke LB, Stanley P et al (1995) Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a childrens cancer group randomized trial. J Clin Oncol 13(7):1687–1696PubMedGoogle Scholar
  15. 15.
    Prados MD, Wara WM, Edwards MHB, Cogen PH (1993) Hyperfractionated craniospinal radiation for primitive neuroectodermal tumors; early results of a pilot study. Int J Radiat Oncol Biol Phys 28:431–438Google Scholar
  16. 16.
    Allen JC, Donahue B, Da Rosso R, Nierenberg A (1996) Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Int J Radiat Oncol Biol Phys 30:1155–1161CrossRefGoogle Scholar
  17. 17.
    Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352(10):978–986PubMedCrossRefGoogle Scholar
  18. 18.
    Kortmann RD, Kuehl J, Timmermann B, Mittler U, Urban C, Burdach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sorense N, Warmuth-Metz M, Bamberg M (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT ‘91. Int J Radiat Oncol Biol Phys Jan 15, 46(2):269–279Google Scholar
  19. 19.
    Packer RJ, Sutton HS, Eltermann R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D’Angio G, Wechsler Jentzsch K et al (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690–698PubMedCrossRefGoogle Scholar
  20. 20.
    Kuehl J, Beck J, Bode U et al (1995) Delayed radiation therapy after postoperative chemotherapy in children less than 3 years of age with medulloblatoma: results of the trial HIT-SKK’87 and preliminary results of the pilot trial HIT-SKK’92. Med Pediatr Oncol 25(Suppl):250Google Scholar
  21. 21.
    Timmermann B, Kortmann RD, Kuhl J, Rutkowski S, Dieckmann K, Meisner C, Bamberg M (2005) Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92. Radiother Oncol 77(3):278–285PubMedCrossRefGoogle Scholar
  22. 22.
    Timmermann B, Kortmann RD, Kuehl J, Rutkowski S, Meisner C, Pietsch T, Deinlein F, Urban C, Warmuth-Metz M, Bamberg M (2006) Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol 24(10):1554–1560PubMedCrossRefGoogle Scholar
  23. 23.
    Seegenschmied MH (1998) Nebenwirkungen in der Onkologie. Springer-Verlag, Berlin, HeidelbergGoogle Scholar
  24. 24.
    Duffner PK, Cohen ME, Sanford RA et al (1995) Lack of efficacy of postoperative chemotherapy and delayed radiotherapy in very young children with pineoblastoma. Med Pediatr Oncol 25:38–44PubMedGoogle Scholar
  25. 25.
    Timmermann B, Kortmann RD, Kuehl J, Meisner C, Dieckmann K, Pietsch T, Bamberg M (2002) Role of Radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol 20(3):842–849PubMedCrossRefGoogle Scholar
  26. 26.
    Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL et al (1994) Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Children’s Cancer Group. J Clin Oncol 12(8):1607–1615PubMedGoogle Scholar
  27. 27.
    Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T (2005) Children’s cancer group: multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. J Clin Oncol 23(30):7621–7631PubMedCrossRefGoogle Scholar
  28. 28.
    Broniscer A, Nicolaides TP, Dunkel IJ, Gardner SL, Johnson J Jr, Allen JC, Sposto R, Finlay JL (2004) High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr Blood Cancer 42(3):261–267PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • Bernward G. Hinkes
    • 1
  • Katja von Hoff
    • 1
  • Frank Deinlein
    • 1
  • Monika Warmuth-Metz
    • 2
  • Niels Soerensen
    • 3
  • Beate Timmermann
    • 4
  • Uwe Mittler
    • 5
  • Christian Urban
    • 6
  • Udo Bode
    • 7
  • Torsten Pietsch
    • 8
  • Paul G. Schlegel
    • 1
  • Rolf D. Kortmann
    • 9
  • Joachim Kuehl
    • 1
  • Stefan Rutkowski
    • 1
  1. 1.Children’s University HospitalUniversity of WuerzburgWuerzburgGermany
  2. 2.Department of NeuroradiologyUniversity of WuerzburgWuerzburgGermany
  3. 3.Department of Pediatric NeurosurgeryUniversity of WuerzburgWuerzburgGermany
  4. 4.Division of Radiation MedicinePaul Scherrer InstituteVilligenSwitzerland
  5. 5.Department of PediatricsUniversity of MagdeburgMagdeburgGermany
  6. 6.Department of PediatricsUniversity of GrazGrazAustria
  7. 7.Department of Pediatric OncologyUniversity of BonnBonnGermany
  8. 8.Department of NeuropathologyUniversity of BonnBonnGermany
  9. 9.Department of Radiation OncologyUniversity of LeipzigLeipzigGermany

Personalised recommendations